CFIC
JAZZ icon

City Financial Investment Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

City Financial Investment Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-23,750
Closed -$3.45M – 103
2017
Q1 		$3.45M Sell
23,750
-1,250
-5% -$163K 0.54% 39
2016
Q4 		$2.73M Buy
+25,000
New +$2.78M 0.5% 37

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

City Financial Investment Company's JAZZ Position: Q2 2017 in Review

City Financial Investment Company sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2017, closing a stake of 23,750 shares — an estimated $3.45M sold.

City Financial Investment Company first reported a position in JAZZ in Q4 2016 and held it in 2 quarters. The position peaked at $3.45M in Q1 2017. 319 funds tracked by Wall St. Rank hold JAZZ as of Q2 2017.

  • City Financial Investment Company reported no remaining Jazz Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • City Financial Investment Company sold 23,750 Jazz Pharmaceuticals shares in Q2 2017, an estimated $3.45M.
  • City Financial Investment Company first reported a position in Jazz Pharmaceuticals in Q4 2016 and held it in 2 quarters.
  • City Financial Investment Company's Jazz Pharmaceuticals position peaked at $3.45M in Q1 2017.
  • 319 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2017.

Based on City Financial Investment Company's 13F filing for Q2 2017, filed 14 Aug 2017.